Antioxidant potential of chlorogenic acid in Age‐Related eye diseases
Pharmacology Research & Perspectives · 2024-02 · 12 (1)
DOI: 10.1002/prp2.1162 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacology Research & Perspectives, online erschienen am 08.01.2024. Verfasst von Yu Tang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The First Hospital of Hunan University of Chinese Medicine, Changsha, China. Hauptthemen laut MEDLINE: Eye Diseases, Diabetic Retinopathy. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Key Program of Administration of Chinese Medicine of Hunan Province of China, Key Project of Educational Commission of Hunan Province of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Oxidative stress is an important mechanism of aging, and in turn, aging can also aggravate oxidative stress, which leads to a vicious cycle. In the process of the brain converting light into visual signals, the eye is stimulated by harmful blue‐light radiation directly. Thus, the eye is especially vulnerable to oxidative stress and becomes one of the organs most seriously involved during the aging process. Cataracts, age‐related macular degeneration (AMD), glaucoma, diabetic retinopathy (DR), and dry eye are inextricably linked to the aging process and oxidative stress. Chlorogenic acid (CGA) has been demonstrated to have antioxidant and anti‐inflammatory activities, and its validity has been established experimentally in numerous fields, including cardiovascular disease, metabolic disorders, cancers, and other chronic diseases. There has previously been evidence of CGA's therapeutic effect in the field of ophthalmopathy. Considering that many ophthalmic drugs lead to systemic side effects, CGA may act as a natural exogenous antioxidant for patients to take regularly, controlling their condition while minimizing side effects. In this paper, in vitro and in vivo studies of CGA in the treatment of age‐related eye diseases are reviewed, and the prospects of CGA's antioxidant application for the eye are discussed. The aim of this review is to summarize the relevant knowledge and provide theoretical support for future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, The First Hospital of Hunan University of Chinese Medicine, Changsha, China.
- Hunan University of Chinese Medicine, Changsha, China.
- Department of Scientific Research, The First Hospital of Hunan University of Chinese Medicine, Changsha, China.
- Hunan Provincial Key Laboratory for Prevention and Treatment of Ophthalmology and Otolaryngology Diseases with Chinese Medicine, Changsha, China.
ORCID-Profile: Xiaolei Yao
Förderung
- Key Program of Administration of Chinese Medicine of Hunan Province of China
- Key Project of Educational Commission of Hunan Province of China
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province of China
Zitieren
APA
Tang, Y., Fang, C., Shi, J., Chen, H., Chen, X., & Yao, X. (2024). Antioxidant potential of chlorogenic acid in Age‐Related eye diseases. Pharmacology Research & Perspectives, 12(1). https://doi.org/10.1002/prp2.1162
Vancouver
Tang Y, Fang C, Shi J, Chen H, Chen X, Yao X. Antioxidant potential of chlorogenic acid in Age‐Related eye diseases. Pharmacology Research & Perspectives. 2024;12(1). doi:10.1002/prp2.1162
BibTeX
@article{Tang2024,
author = {Tang, Yu and Fang, Chi and Shi, Jian and Chen, Huimei and Chen, Xiong and Yao, Xiaolei},
title = {Antioxidant potential of chlorogenic acid in Age‐Related eye diseases},
journal = {Pharmacology Research & Perspectives},
year = {2024},
volume = {12},
number = {1},
doi = {10.1002/prp2.1162}
}
EUVIMED